Drug Trial Radar · NCT07335588
A 52-Week Trial to Investigate the Efficacy and Safety of Delgocitinib Cream in Adult Participants With Lichen Sclerosus
Last checked: Nov 20, 2026Latest source record: Nov 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
552
Planned (sponsor's estimate)
Start
May 1, 2026
Primary completion
Mar 10, 2028
Study completion Dec 29, 2028
Sponsor
- Lead sponsor
- LEO PharmaIndustry
- Sponsor type
- Industry
- First posted
- Jan 13, 2026
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Double (participant, investigator)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The main objective of the study is to evaluate the efficacy of twice daily applications of delgocitinib cream compared with cream vehicle in the treatment of adult participants with mild to severe lichen sclerosus (LS). The researchers are focusing on female participants because LS is more likely to affect females compared to males. The trial is conducted in 2 parts. Part 1 of the trial enrolls female participants with LS and results in the selection of the optimal dose for Part 2. The selected dose will then be evaluated in Part 2, which will enroll both female and male participants. Assessment of efficacy and safety of delgocitinib cream in male participants with LS will be evaluated in a substudy. For each participant, the trial will last at least 55 weeks and up to 60 weeks.
Conditions
- Lichen Sclerosus
Interventions
DelgocitinibDrug
Participants will receive delgocitinib BID via topical application.
Cream VehicleDrug
Participants will receive cream vehicle BID via topical administration.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Number of Participants Achieving Investigator's Global Assessment of Lichen Sclerosus (IGA-LS) Treatment Success (TS) at Week 12Time frame: Week 12
Locations
35 sites in 3 countries. Site status is shown where the registry gives one.
LEO Pharma Investigational Site
Birmingham, Alabama · Recruiting
LEO Pharma Investigational Site
Phoenix, Arizona · Recruiting
LEO Pharma Investigational Site
Scottsdale, Arizona · Recruiting
LEO Pharma Investigational Site
Fremont, California · Recruiting
LEO Pharma Investigational Site
Middlebury, Connecticut · Recruiting
LEO Pharma Investigational Site
Washington D.C., District of Columbia · Recruiting
LEO Pharma Investigational Site
Boca Raton, Florida · Recruiting
LEO Pharma Investigational Site
Clearwater, Florida · Recruiting
LEO Pharma Investigational Site
Jacksonville, Florida · Recruiting
LEO Pharma Investigational Site
Miami, Florida · Recruiting
LEO Pharma Investigational Site
Tampa, Florida · Recruiting
LEO Pharma Investigational Site
Chicago, Illinois · Recruiting
LEO Pharma Investigational Site
Northville, Michigan · Recruiting
LEO Pharma Investigational Site
Rochester, Minnesota · Recruiting
LEO Pharma Investigational Site
New York, New York · Recruiting
LEO Pharma Investigational Site
New York, New York · Recruiting
LEO Pharma Investigational Site
Chapel Hill, North Carolina · Recruiting
LEO Pharma Investigational Site
Bexley, Ohio · Recruiting
LEO Pharma Investigational Site
Portland, Oregon · Recruiting
LEO Pharma Investigational Site
Philadelphia, Pennsylvania · Recruiting
LEO Pharma Investigational Site
Dallas, Texas · Recruiting
LEO Pharma Investigational Site
Murray, Utah · Recruiting
LEO Pharma Investigational Site
Winnipeg, Manitoba, Canada · Recruiting
LEO Pharma Investigational Site
Fredericton, New Brunswick, Canada · Recruiting
LEO Pharma Investigational Site
Guelph, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Newmarket, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Richmond Hill, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Toronto, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Toronto, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Waterloo, Ontario, Canada · Recruiting
LEO Pharma Investigational Site
Montreal, Quebec, Canada · Recruiting
LEO Pharma Investigational Site
Québec, Quebec, Canada · Recruiting
LEO Pharma Investigational Site
Saskatoon, Saskatchewan, Canada · Recruiting
LEO Pharma Investigational Site
Liverpool, United Kingdom · Recruiting
LEO Pharma Investigational Site
London, United Kingdom · Recruiting
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.